Texas Oncology-Dallas Presbyterian Hospital — Dallas, Texas

Texas Oncology-Dallas Presbyterian Hospital is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Dallas Presbyterian Hospital has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Breast Cancer, Breast Neoplasms.

Sponsors: Acrivon Therapeutics, Pfizer, Nektar Therapeutics.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Dallas Presbyterian Hospital?

Texas Oncology-Dallas Presbyterian Hospital has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Dallas Presbyterian Hospital conducted?

Texas Oncology-Dallas Presbyterian Hospital has 13 clinical trials on record, with 2 currently active. Their work covers Endometrial Adenocarcinoma, Breast Cancer, Breast Neoplasms.

Is Texas Oncology-Dallas Presbyterian Hospital accredited by Crixeo Health?

Yes — Texas Oncology-Dallas Presbyterian Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Dallas Presbyterian Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.